Praxis Precision Medicines Stock Current Valuation
| PRAX Stock | USD 80.17 0.72 0.91% |
Valuation analysis of Praxis Precision Med helps investors to measure Praxis Precision's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. Enterprise Value is likely to rise to about 116.3 M in 2024, whereas Enterprise Value Over EBITDA is likely to drop (0.57) in 2024. Fundamental drivers impacting Praxis Precision's valuation include:
Price Book 3.9047 | Enterprise Value 1.1 B | Enterprise Value Ebitda (6.86) | Price Sales 930.961 | Enterprise Value Revenue 709.5443 |
Overvalued
Today
Please note that Praxis Precision's price fluctuation is very steady at this time. Calculation of the real value of Praxis Precision Med is based on 3 months time horizon. Increasing Praxis Precision's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Praxis Precision is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Praxis Stock. However, Praxis Precision's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 80.17 | Real 42.82 | Target 7.08 | Hype 80.74 |
The intrinsic value of Praxis Precision's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Praxis Precision's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Praxis Precision Medicines helps investors to forecast how Praxis stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Praxis Precision more accurately as focusing exclusively on Praxis Precision's fundamentals will not take into account other important factors: Praxis Precision Medicines Company Current Valuation Analysis
Praxis Precision's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Praxis Precision Current Valuation | 1.14 B |
Most of Praxis Precision's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Praxis Precision Medicines is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Praxis Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Praxis Precision is extremely important. It helps to project a fair market value of Praxis Stock properly, considering its historical fundamentals such as Current Valuation. Since Praxis Precision's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Praxis Precision's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Praxis Precision's interrelated accounts and indicators.
Click cells to compare fundamentals
Praxis Current Valuation Historical Pattern
Today, most investors in Praxis Precision Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Praxis Precision's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Praxis Precision current valuation as a starting point in their analysis.
Praxis Precision Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Praxis Precision Medicines has a Current Valuation of 1.14 B. This is 92.07% lower than that of the Biotechnology sector and 75.49% lower than that of the Health Care industry. The current valuation for all United States stocks is 93.15% higher than that of the company.
Praxis Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Praxis Precision's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Praxis Precision could also be used in its relative valuation, which is a method of valuing Praxis Precision by comparing valuation metrics of similar companies.Praxis Precision is currently under evaluation in current valuation category among its peers.
Praxis Precision ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Praxis Precision's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Praxis Precision's managers, analysts, and investors.Environmental | Governance | Social |
Praxis Fundamentals
| Return On Equity | -0.64 | ||||
| Return On Asset | -0.39 | ||||
| Operating Margin | (188.20) % | ||||
| Current Valuation | 1.14 B | ||||
| Shares Outstanding | 18.64 M | ||||
| Shares Owned By Insiders | 0.24 % | ||||
| Shares Owned By Institutions | 99.76 % | ||||
| Number Of Shares Shorted | 1.53 M | ||||
| Price To Book | 3.90 X | ||||
| Price To Sales | 930.96 X | ||||
| Revenue | 2.45 M | ||||
| EBITDA | (125.94 M) | ||||
| Net Income | (123.28 M) | ||||
| Cash And Equivalents | 165.4 M | ||||
| Cash Per Share | 3.70 X | ||||
| Total Debt | 2.5 M | ||||
| Debt To Equity | 0.03 % | ||||
| Current Ratio | 4.56 X | ||||
| Book Value Per Share | 21.52 X | ||||
| Cash Flow From Operations | (111.14 M) | ||||
| Short Ratio | 4.75 X | ||||
| Earnings Per Share | (9.17) X | ||||
| Price To Earnings To Growth | 0.03 X | ||||
| Target Price | 145.6 | ||||
| Number Of Employees | 82 | ||||
| Beta | 2.69 | ||||
| Market Capitalization | 1.49 B | ||||
| Total Asset | 87.95 M | ||||
| Retained Earnings | (653.92 M) | ||||
| Working Capital | 69.13 M | ||||
| Net Asset | 87.95 M |
About Praxis Precision Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Praxis Precision Medicines's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Praxis Precision using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Praxis Precision Medicines based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Praxis Stock Analysis
When running Praxis Precision's price analysis, check to measure Praxis Precision's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Praxis Precision is operating at the current time. Most of Praxis Precision's value examination focuses on studying past and present price action to predict the probability of Praxis Precision's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Praxis Precision's price. Additionally, you may evaluate how the addition of Praxis Precision to your portfolios can decrease your overall portfolio volatility.